Recent Quotes

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on the development of drug products that are intended to improve the survival and quality of life for patients who have an unmet medical need. The company's lead product, PCS499 is an oral tablet that is an analog of an active metabolite of an already approved drug. It focuses on fibrotic related diseases such as focal segmental glomerulosclerosis, idiopathic pulmonary fibrosis. Its pipeline products comprise PCS6422, PCS12852, and PCS100.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-06
REV		(EXPECTED)2021-08-06

Q1 2021		Est.		Actual		Surprise
EPS		-0.100		-0.140		-0.0400
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
PCSA	Processa Pharmaceuticals	7.00	0.10	1.45%		109M

Processa Pharmaceuticals Frequently Asked Questions

How do I buy Processa Pharmaceuticals (PCSA) stock?

You can purchase shares of Processa Pharmaceuticals (NASDAQ: PCSA) through any online brokerage.

View our list of the best stock brokerages.

Who are Processa Pharmaceuticals's (PCSA) competitors?

Other companies in Processa Pharmaceuticals’s space includes: Graybug Vision (NASDAQ:GRAY), Opiant Pharmaceuticals (NASDAQ:OPNT), Cocrystal Pharma (NASDAQ:COCP), Onconova Therapeutics (NASDAQ:ONTX) and Ocuphire Pharma (NASDAQ:OCUP).

What is the target price for Processa Pharmaceuticals (PCSA) stock?

The latest price target for Processa Pharmaceuticals (NASDAQ: PCSA) was reported by Craig-Hallum on October 28, 2020. The analyst firm set a price target for 12.00 expecting PCSA to rise to within 12 months (a possible 71.43% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Processa Pharmaceuticals (PCSA)?

The stock price for Processa Pharmaceuticals (NASDAQ: PCSA) is $7 last updated Fri Jul 23 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Processa Pharmaceuticals (PCSA) pay a dividend?

There are no upcoming dividends for Processa Pharmaceuticals.

When is Processa Pharmaceuticals (NASDAQ:PCSA) reporting earnings?

Processa Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 6, 2021.

Is Processa Pharmaceuticals (PCSA) going to split?

There is no upcoming split for Processa Pharmaceuticals.

What sector and industry does Processa Pharmaceuticals (PCSA) operate in?

Processa Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.